Prospective Validation of the SWEET Tool for Pre-diction of Preintervention ERCP Procedure Time.

Recruiting Observational Study
Endoscopic Retrograde Cholangio-Pancreatography
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Observational
Participants needed
363 (estimated)
Sponsor
Universitair Ziekenhuis Brussel · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Endoscopic retrograde cholangiopancreatography (ERCP) is a frequently performed procedure worldwide. The procedure combines endoscopy and X-ray imaging to diagnose and treat problems in the bile and pancreatic ducts, most commonly stones or strictures. Until the recent publication of Waldthaler et al., there was little evidence about what patient- and procedure-related factors determine a priori …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age \> 18 years * First or redo-ERCP * Intraductal endoscopy * ERCPs performed by fellows under supervision Exclusion Criteria: * ERCPs in altered anatomy * ERCPs combined with therapeutic EUS interventions
Contacts

Helena Degroote, MD, PhD

+32 2 477 68 11

helena.degroote@uzbrussel.be

CONTACT